Monday, July 7, 2025
Home Tags BARDA

Tag: BARDA

Vaxxas secures $2M grant from BARDA to develop needle-free mRNA vaccines

Vaxxas, a clinical-stage biotechnology company specializing in high-density microarray patch (HD-MAP) vaccine delivery, has been awarded a $2 million (AUD 3.2 million) grant as a Concept Stage winner in the United States Biomedical Advanced Research and Development Authority’s (BARDA) $50 million Patch Forward Prize. 

SAB Biotherapeutics awarded $57.5 to manufacture its therapeutic candidate for COVID-19

Clinical stage biopharma company SAB Biotherapeutics has been awarded $57.5 million from BARDA and the US Department of Defence for the manufacturing of SAB-185,...
Advertisement

Golden Beach Fencing

Com2 Communications

Power Machinery Australia

Featured Article

Don’t get left behind: Manufacturing’s urgent need for digital transformation

As digital transformation reshapes industries worldwide, manufacturers in Australia and beyond are finding themselves at the forefront of an evolution. This shift presents opportunities for companies looking to improve efficiency, drive innovation, and boost growth.